Skyla Haily Mendoza, MSN, FNP-BC
Family · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Skyla Haily Mendoza’s office at (408) 228-3700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
Original Medicare doctor bills
$1,830,225
Medicare paid this office $1,830,225 for 136 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, tocilizumab, 1 mg | 21 | $215,669 | None |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20 | $215,206 | None |
| Injection, golimumab, 1 mg, for intravenous use | 21 | $91,253 | None |
| Injection, infliximab, excludes biosimilar, 10 mg | 18 | $70,260 | None |
| Administration of chemotherapy into vein, 1 hour or less | 85 | $32,651 | $119 |
See all 10 services
| Injection, tocilizumab, 1 mg | 21 | $215,669 | None |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20 | $215,206 | None |
| Injection, golimumab, 1 mg, for intravenous use | 21 | $91,253 | None |
| Injection, infliximab, excludes biosimilar, 10 mg | 18 | $70,260 | None |
| Administration of chemotherapy into vein, 1 hour or less | 85 | $32,651 | $119 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 40 | $8,014 | $57 |
| Administration of chemotherapy into vein, each additional hour | 28 | $2,526 | $24 |
| Injection of drug or substance under skin or into muscle | 20 | $1,470 | $12 |
| Injection of additional new drug or substance into vein | 14 | $341 | $14 |
| Injection, methylprednisolone sodium succinate, 5 mg | 12 | $90 | None |
Who their Medicare patients are
136 Original Medicare patients in 2024. Average age 73 · Women 68% · Health risk score 1.53. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71% · Coronary heart disease 32% · Chronic kidney disease 23% · Diabetes 21% · Depression 21% · COPD 16% · Atrial fibrillation 15% · Heart failure 14% · Cancer 13% · Stroke 9%.
The office billed $6,600,004, Medicare allowed $2,299,849 and paid $1,830,225; for 96,245 services of 40 kinds; $1,760,055 of it was for drugs given in the office and $70,170 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 136 | 96,245 | 73 | 1.53 | $6,600,004 | $1,830,225 |
| 2023 | 55 | 9,488 | 73 | 1.19 | $727,303 | $176,781 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Administration of chemotherapy into vein, 1 hour or less | 32 | $4,076 | $120 |
| Injection of drug or substance under skin or into muscle | 14 | $354 | $12 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 2 | 2 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lundbeck | Vyepti | $125 | 1 payment
|
See the published payment
| Lundbeck | Meals · 2025-01-16 | Vyepti | $125 |
See earlier years (2024)
2024: $142
| Argenx US | Vyvgart Hytrulo | $125 | 1 payment
|
| Lundbeck | Vyepti | $17 | 1 payment
|
Professional record
- NPI
- 1992494017
- Licence
- CA 95025051
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 717 E El Camino Real Ste 5, Sunnyvale, CA, 94087
- NPI first listed
- 2023-05-04
- NPI last updated
- 2024-03-19
- NPI record certified
- 2024-03-19
This is when the NPI record was last certified, not a medical board exam.